SEC Form D · filed July 14, 2021
Spero Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (35)
Cynthia C. Smith · Cambridge, MADirectorTimothy C. Keutzer · Cambridge, MAExecMilind Deshpande · Cambridge, MADirectorTamara C. Joseph · Cambridge, MAExecScott C. Jackson · Cambridge, MADirectorPatrick E. Vink · Cambridge, MADirectorSatyavrat E. Shukla · Cambridge, MAExecAnkit Mahadevia · Cambridge, MAExec · DirectorFrank E. Thomas · Cambridge, MADirectorCristina E. Larkin · Cambridge, MAExecInderpal M. Singh · New York, NYDirectorAndreas Muehler · New York, NYDirectorKevin S. Lavelle · Dallas, TXDirectorVivekanand Arza · San Jose, CAExecJohn Wires · Shawnee, KSExecLex Ferenda Litigation Funding GP LLC · Rye Brook, NYDirectorGlenn M. Whaley · New York, NYExec · DirectorLex Ferenda Litigation Funding LLC · Rye Brook, NYDirectorDaniel Vitt · New York, NYExecDavid E. Melnick · Cambridge, MAExecJohn C. Pottage, Jr · Cambridge, MADirectorJean-Francois Formela · Broomfield, CODirectorDaniel R. Karlin · DALLAS, TXDirectorRachel Kern · DALLAS, TXExecJ. A. Antonelli · Provo, UTDirectorBarry D. Mower · Provo, UTDirectorDeborah Jones · Raleigh, NCExecMatthew Hobbs · Raleigh, NCDirectorMichael Burt · Edinburgh, United KingdomExecAngus Burt · Edinburgh, United KingdomDirectorKevin D. Costello · Portland, MEExec · DirectorDavid E. Melnick · Cambridge, MAExecCristina E. Larkin · Cambridge, MAExecJohn C. Pottage, Jr · Cambridge, MADirectorJean-Francois Formela · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗